Articles published

According to Zacks, “NxStage Medical, Inc. is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative systems for the treatment of end-stage renal disease, or ESRD, and acute kidney ...

According to Zacks, “NxStage Medical, Inc. is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative systems for the treatment of end-stage renal disease, or ESRD, and acute kidney ...

The Chief Executive Officer of NxStage Medical, Inc. (NASDAQ:NXTM) 13.99 -0.03 -0.21% and company's insider Jeffrey Burbank made a sale of 20,000 shares of the stock exchange listed company calculated based on the stock price per share of $15.6 per ...

NxStage Medical, Inc. (NASDAQ:NXTM) dropped by -1.4 or -0.22 points during the last session to $15.48 per share. One of the highlights of the day was the net money flow figure, which stood at $0.51 million even as the stock accepted $0.86 million in ...

As announced in a report that was submitted to the (SEC) on 16-06-2015, Winifred Swan, SVP and General Counsel of NxStage Medical, Inc. (NASDAQ:NXTM) 13.94 -0.16 -1.13% and an insider with a special knowledge about the corporation, unloaded ...

Mr. Joseph Turk, the crucial President at NxStage Medical, Inc. (NASDAQ:NXTM) 13.94 -0.16 -1.13% has a few days ago been involved with sold with a broker of 2,839 shares of the Massachusetts-based Nxstage Medical Inc, valued at $16.0 per share.